Trial Profile
Effect of TAS-116 on cardiovascular safety parameters in patients with advanced solid tumors
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2021
Price :
$35
*
At a glance
- Drugs Pimitespib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Taiho Pharmaceutical
- 10 Oct 2018 New trial record